Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
PHAT | Phathom Pharmaceuticals, Inc. | CFO and CBO | $1.56M | -$70.4K | -4.32% | Apr 7, 2025 |
URGN | UroGen Pharma Ltd. | Chief Financial Officer | $94.5K | Jan 31, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|